May 14, 2026 08:45AM
May 14, 2026 08:40AM
May 14, 2026 08:40AM
Mar 27, 2026 12:47PM
Mar 27, 2026 08:00AM
Feb 20, 2026 08:50AM
Feb 20, 2026 08:50AM Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development
Feb 11, 2026 08:35AM
Feb 11, 2026 08:35AM
Jan 14, 2026 09:15AM
Dec 9, 2025 07:02AM
Dec 9, 2025 07:00AM
Dec 9, 2025 07:00AM
Dec 9, 2025 07:00AM Senti Bio Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for SENTI-202 in the Treatment of Adults with Relapsed or Refractory Acute Myeloid Leukemia
Nov 3, 2025 09:05AM
Aug 7, 2025 08:05AM
Aug 7, 2025 08:05AM
Aug 5, 2025 08:30AM
Aug 5, 2025 08:30AM
Jun 30, 2025 09:15AM
Jun 18, 2025 07:01AM Senti Biosciences (SNTI) Granted U.S. FDA Orphan Drug Designation for Use of First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, SENTI-202
Jun 18, 2025 07:00AM
May 9, 2024 04:05PM
Mar 21, 2024 04:05PM
Jan 5, 2024 04:05PM
Jan 5, 2024 04:05PM
Dec 22, 2023 06:30AM
Dec 22, 2023 06:30AM Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
Nov 13, 2023 04:15PM
Aug 11, 2023 08:35AM
May 20, 2023 08:05AM
May 2, 2023 04:45PM
May 2, 2023 04:45PM
Mar 22, 2023 05:09PM
Jan 27, 2023 08:00AM Senesco Technologies, Inc. (SNTI) Announces Pipeline Prioritization to Focus on Logic Gated Cell Therapies; Updates Cash Runway Guidance
Jan 27, 2023 08:00AM
Jan 27, 2023 08:00AM
Nov 10, 2022 07:55AM
Nov 10, 2022 07:55AM
Jun 9, 2022 07:33AM
Jun 9, 2022 07:30AM

322,084 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All